Yungjin, Itochu sign MOU on cefcapene, third generation cephalosporin

Published: 2008-04-09 06:56:00

Updated: 2008-04-09 06:56:00

Yungjin Pharm and Itochu Chemical Frontier Corporation, a global wide trading company in Japan, signed a memorandum of understanding on April 3 to enhance their strategic alliance in the field of pharmaceutical bulks.

Under the agreement, Yungjin will supply to Itochu cefcapene pivoxil hydroch...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK